Denali Therapeutics Inc.

DNLI • NASDAQ • Stock Fundamentals

Denali Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ryan J. Watts, with a market cap of $3.3B.

Market Cap$3.3B

Employees375.0

CEORyan J. Watts

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 6 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Denali Therapeutics Inc.

Denali Therapeutics Inc. (DNLI) has a market capitalization of $3.3B and trades on NASDAQ.

Denali Therapeutics Inc. has approximately 375 employees.